The effectiveness of Autologous Blood Injections for the treatment of mid portion Achilles tendinopathy- a double blind randomised control trial.

Not Applicable

Completed

• Conditions: Achilles Tendinopathy; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12610000824066
• Lead Sponsor: Professor Ngaire Kerse

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-10-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

patients presenting to sports medicine/physiotherapy/ general practice clinics with first presentation of mid portion Achilles tendinopathy of at least 3 months duration

Exclusion Criteria

Bilateral Achilles tendinopathy, significant coagulopathy predisposing to bleeding, previous adjuvant treatment of the Achilles tendinopathy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VISA-A score[A VISA-A score will be done at randomisation (baseline) and again at 1,2,3,& 6 months subsequent to this.]

Secondary Outcome Measures

Name	Time	Method
ikert score to assess overall improvement<br>Ability to return to tendon loading sport [6 months]